Asthma

The authors found that asthma severity was associated with a higher risk of type 2 diabetes, with the risk increasing in line with severity, but not asthma duration.

Although dry-powder and soft-mist inhalers had significantly lower emissions, they represented nearly two-thirds of inhaler costs but one-third of claims.

The authors also found that there was a higher frequency of miscarriages compared with women who did not have asthma.

Pharmacists can help address the significant asthma health disparities among racial, ethnic, and socioeconomic groups to help improve outcomes.

To help with treatment response and compliance as well as optimize treatment, communication between patients and health care providers is necessary.

A recent study found that a weight-adjusted waist index was an independent predictor of all-cause-, cardiovascular-, cancer-, and respiratory-related mortality in patients with asthma.

The exhaled breath condensate mask was able to successfully monitor and accurately detect breath for nitrate in patients with asthma or chronic obstructive pulmonary disease.

Using 1 nicotine-containing electronic cigarette was significantly correlated with an increase in residual volume and total lung capacity in patients with asthma.

In Finland, season of birth, notably autumn and winter, was associated with the development of asthma and allergic rhinitis.

Communities that are impacted by increased wildfires can experience increased health risks, particularly among those who have asthma or chronic obstructive pulmonary disease.

The study authors recommend that health care professionals are aware of the connections, notably in adolescent patients and those with moderate to severe psoriasis.

Pharmacists played a crucial role in providing asthma action plans and enhancing patient education, despite challenges, and study limitations.

A number of asthma-related emergency room visits are a result of viruses, but certain airborne pollens—notably Cupressaceae and tree pollens—are also contributors.

Compared with placebo, tezepelumab reduced the annual asthma exacerbation rate in multiple subpopulations and asthma-related comorbidities.

The molecule can be a potential treatment that counters effects of early-life antibiotics, which can impact the gut microbiota and increase the risk of childhood atopy and asthma.

Studies show an increased prevalence of autism spectrum disorder in children of mothers; mouse models have shown links between maternal asthma and altered behavior and brain function.

The authors emphasize that clinical research should focus on real-world difficulties, and pediatric asthma control should be seen as a health care priority.

The findings demonstrate that the mG900 region plays a significant role in Type-2 helper T (Th2) cell differentiation and enhances allergic airway inflammation.

Dupilumab may improve disease severity in children with eosinophilic esophagitis (EoE).

Higher vaccination rates were associated with less prevalent asthmatic symptoms, but additional research is needed to confirm these findings.

In 2 different dose groups, the majority of patients with eosinophilic esophagitis aged 1 to 11 achieved histologic remission at week 16 compared with patients treated with placebo.

However, more research is needed to effectively integrate this biomarker into individualized asthma management strategies for pediatric patients.

The findings show that the largest gaps are among pediatric patients with persistent asthma.

Mice with asthma that were fed bread with Saccharomyces cerevisiae UFMG A-905 yeast showed reduced airway inflammation and decreased IL-5 and IL-13 concentrations, and effects increased when combined with microcapsules.

The findings also show that skin testing positivity for perennial allergens was higher in patients with childhood-onset asthma compared with those with adult-onset asthma.

The study results also found that exposure to tree canopy area may protect children from asthma development; however, efficacy decreased as weed pollen exposure increased.

Patients with undiagnosed asthma or COPD who received usual care from their primary providers were more likely to visit the hospital or specialists because of respiratory illness.

By improving health insurance coverage and cost of inhalers, such as out-of-pocket caps, access to care can be increased. Some companies are aiming to improve access by implementing price caps.

Adults who did not report past 3-day electronic nicotine delivery system use did not have an increased risk of asthma incidence.

A review of asthma guidelines, pharmacotherapy, and the role of the pharmacist.